Effect of monoamine oxidase inhibitors on rat paw edema induced by various phlogistic agents.

[1]  M. Fekete,et al.  Monoamine oxidase inhibiting properties of AB-15-Comparison with tranylcypromine, nialamide and pargyline , 1969 .

[2]  P. M. Lish,et al.  Studies on the acute inflammatory response. I. Involvement of the central nervous system in certain models of inflammation. , 1968, The Journal of pharmacology and experimental therapeutics.

[3]  I. Bonta,et al.  Significance of the kinin system in rat paw oedemas and drug effects on it. , 1967, European journal of pharmacology.

[4]  P. A. Shore.  The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase. , 1966, Pharmacological reviews.

[5]  G. B. West,et al.  The role of the nervous system in local inflammatory responses , 1965, The Journal of pharmacy and pharmacology.

[6]  S. Spector.  MONOAMINE OXIDASE IN CONTROL OF BRAIN SEROTONIN AND NOREPINEPHRINE CONTENT , 1963, Annals of the New York Academy of Sciences.

[7]  J. Gylys,et al.  PHARMACOLOGICAL AND TOXICOLOGICAL PROPERTIES OF 2‐METHYL‐3‐PIPERIDINOPYRAZINE, A NEW ANTIDEPRESSANT * , 1963, Annals of the New York Academy of Sciences.

[8]  B. Northover.  The permeability to plasma proteins of the peritoneal blood vessels of the mouse, and the effect of substances that alter permeability. , 1963, The Journal of pathology and bacteriology.

[9]  G. Vogel,et al.  [On the inhibition of various rat paw edemas by serotonin antagonists]. , 1961, Arzneimittel-Forschung.

[10]  R. Amelunxen,et al.  Quantitative considerations of influenza virus neutralization. 1. Number of antibody molecules per virus particle. , 1960, Journal of bacteriology.

[11]  I. Setnikar,et al.  Antiphlogistic activity of iproniazid. , 1959, British journal of pharmacology and chemotherapy.

[12]  G. B. West,et al.  Inhibition by various substances of oedema formation in the bind-paw of the rat induced by 5-hydroxytryptamine, histamine, dextran, egg-white and compound 48/80. , 1958, British journal of pharmacology and chemotherapy.

[13]  V. Erspamer.  Participation of 5-hydroxytryptamine in physiopathological processes , 1966 .